Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$162,988
+$39,872 QoQ
Shares Held
1,040
+29.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,337
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Salomon & Ludwin, LLC holds $6,615,602 across 15 Drug Manufacturers - General names. NVS ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,638 | $1,964,666 | |
| 2 | JNJ |
Johnson & Johnson
|
6,720 | $1,706,678 | |
| 3 | ABBV |
AbbVie Inc.
|
5,275 | $1,327,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,954 | $379,589 | |
| 5 | AMGN |
Amgen Inc
|
907 | $328,442 | |
| 6 | AZN |
Astrazeneca PLC
|
1,003 | $190,188 | |
| 7 | NVS |
Novartis AG
This page
|
1,040 | $162,988 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,281 | $131,431 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162,988 | 1,040 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $123,116 | 806 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $103,402 | 750 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $58,605 | 457 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,904 | 24 | Shares | Sole | 2025-07-29 | |
| No filing history on record for this holder in this stock. | ||||||